PCI 3.06.26

Current Edition

Current Features

Subsection - Neurodegenerative Diseases

From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment

Continue reading

Subsection - Oncology

Essential DMPK Strategies for IND Success

Continue reading

Subsection - Cell and Gene Therapy

When the Gene Editing Guide is the Drug

Continue reading

Upcoming Events

CPHI 2027
AI in Drug Discovery
DDL 2026
Biotechnology Show 13.02.26

Advertisement

Advertisement

A&M Stabtest April 26

Advertisement

Biopharma Group – 19th March 2025

Advertisement

Micron View

Advertisement

Bachem skyscraper

Advertisement

Fujifilm
news

EMA faces higher staff losses ahead of move to Amsterdam

The European Medicines Agency's necessary relocation to Amsterdam following the U.K.'s Brexit vote has moved into its next phase with a business continuity plan "aime...
Continue Reading →
news

Epizyme trims back blood cancer trials for lead drug, stock sinks

Epizyme is scaling back research on its lead drug as a treatment for a type of blood cancer after reviewing discouraging data, the company announced Thursday in its s...
Continue Reading →
news

Correcting sickle cell–causing mutation with efficient CRISPR-Cas9 genome editing

Research published in Nature Medicine describes collaborative effort to reduce off-target CRISPR-Cas9 genome editing – removing barriers for human therapeutic applica...
Continue Reading →
news

Laekna acquires exclusive rights for two oral Akt inhibitors

Laekna has signed an agreement with Novartis Pharma to develop and commercialize two oral Novartis clinical-stage oncology assets. Laekna Inc., a biotechnology compa...
Continue Reading →
news

Akouos raises $50M to take hearing loss gene therapy into humans

Akouos has raised $50 million to take a gene therapy treatment for hearing loss into the clinic. The Boston-based biotech unveiled the series A round alongside the ap...
Continue Reading →
news

Mayo Clinic pinpoints genes that raise the risk of triple-negative breast cancer

The ability to identify women who face the highest risk of triple-negative breast cancer could save lives, but only one inherited mutation—in the gene BRCA1—has been ...
Continue Reading →
news

Regeneron, bluebird bio Partner on Cell Therapy Development

The companies will collaborate on the discovery, development, and commercialization of cell therapies for cancer. Regeneron Pharmaceuticals and bluebird bio announce...
Continue Reading →
news

Alder BioPharmaceuticals® to Host Conference Call to Discuss Second Quarter 2018 Financial and Operating Results

Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today anno...
Continue Reading →
news

FDA rejects Insys opioid pain spray

Insys Therapeutics said Friday that the Food and Drug Administration issued it a Complete Response Letter rejecting the company’s New Drug Application for Buvaya. ...
Continue Reading →
news

3D printed scaffolds can regrow damaged nerves

Researchers from the University of Saskatchewan in Canada are looking at how we can use 3D printing to help damaged nervous systems to regrow Scientists have develo...
Continue Reading →

Advertisement

Richter: Wed 23 October 2024, 09:03

Advertisement

Aseptic Tech

Advertisement

Steribar – 12.05.2025

Advertisement

PharmExcel

Advertisement

Polypure hompage

Advertisement

Gen Xpro

Advertisement

Alphinity

Advertisement

Crown Bioscience

Advertisement

Shimadzu

Advertisement

CPC